PCS HOLDING CORP
15-15D, 1995-01-27
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: DREYFUS NEW YORK TAX EXEMPT MONEY MARKET FUND/NY, N-30D, 1995-01-27
Next: PCS HOLDING CORP, 15-12G/A, 1995-01-27



<PAGE>
 
                                                             OMB APPROVAL
                                                   -----------------------------
                                                   OMB Number:         3235-0167
                                                   Expires:    November 30, 1995
                                                   Estimated average burden
                                                   hours per form ......... 1.50


                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549


                                    FORM 15


     CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
   12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
   REPORTS UNDER SECTION 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

                             Commission File Number           1-9626
                                                    ----------------------------

            PCS Holding Corporation (formerly McKesson Corporation)
- --------------------------------------------------------------------------------
             (Exact Name of Registrant as specified in its charter)

c/o Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, 46285
- --------------------------------------------------------------------------------
                               (317) 276-2000
- --------------------------------------------------------------------------------
  (Address, including zip code, and telephone number, including area code, of
                   registrant's principal executive offices)

              4-1/2% Exchangeable Subordinated Debentures due 2004
                             8-5/8% Notes due 1998
                    8.75% Series A Medium Term Notes due 1997
- --------------------------------------------------------------------------------
            (Title of each class of securities covered by this Form)

                                      None
- --------------------------------------------------------------------------------
(Title of all other classes of securities for which a duty to file reports under
                        section 13(a) or 15(d) remains)

 Please place an X in the box(es) to designate the appropriate provision(s)
relied upon to terminate or suspend the duty to file reports:

        Rule 12g-4(a)(1)(i)  [     ]     Rule 12h-3(b)(1)(ii)  [     ]
        Rule 12g-4(a)(1)(ii) [     ]     Rule 12h-3(b)(2)(i)   [     ]
        Rule 12g-4(a)(2)(i)  [     ]     Rule 12h-3(b)(2)(ii)  [     ]
        Rule 12g-4(a)(2)(ii) [     ]     Rule 15d-6            [  x  ]
        Rule 12h-3(b)(1)(i)  [     ]

 Approximate number of holders of record as of the certification or notice date:
   4-1/2% Exchangeable Subordinated Debentures due 2004    66
                                                          ----
   8-5/8% Notes Due 1998     25 
                            ----  
   8.75% Series A Medium Term Notes Due 1997    2
                                               ---
    Pursuant to the requirements of the Securities Exchange Act of 1934 PCS
Holding Corporation has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.

DATE: January 27, 1995           BY:/s/ Mitchell E. Daniels, Jr.
     ------------------------      ---------------------------------------------
                                   Mitchell E. Daniels, Jr.
                                   Chairman and President

Instruction:  This form is required by Rules 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934.  The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed.  It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person.  The name and title of the
person signing the form shall be typed or printed under the signature.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission